1-11 of 11
Dawn Jones
Close
Sort by
Journal Articles

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

Clinical Trials & Observations
John Magenau, Hiromi Tobai, Attaphol Pawarode, Thomas Braun, Edward Peres, Pavan Reddy, Carrie Kitko, Sung Choi, Gregory Yanik, David Frame, Andrew Harris, Harry Erba, Lisa Kujawski, Kojo Elenitoba-Johnson, Jennifer Sanks, Dawn Jones, Sophie Paczesny, James Ferrara, John Levine, Shin Mineishi
Journal: Blood
Blood (2011) 118 (15): 4258–4264.
https://doi.org/10.1182/blood-2011-06-358010
Published: 2011
Includes: Supplemental data
Journal Articles

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

Sophie Paczesny, MD, PhD, Thomas Braun, PhD, Mark Vander Lugt, MD, Andrew Harris, MD, Bryan Fiema, James Hernandez, Sung Choi, MD, Carrie Kitko, MD, John Magenau, MD, Gregory Yanik, MD, Edward M. Peres, MD, Attaphol Pawarode, MD, Shin Mineishi, MD, Joel Whitfield, Dawn Jones, RN, Daniel Couriel, MD, Pavan Reddy, MD, Samir Hanash, MD, PhD, James L.M. Ferrara, MD, DSc, John E. Levine, MD, MS
Journal: Blood
Blood (2010) 116 (21): 675.
https://doi.org/10.1182/blood.V116.21.675.675
Published: 2010
Journal Articles

A biomarker panel for acute graft-versus-host disease

Sophie Paczesny, Oleg I. Krijanovski, Thomas M. Braun, Sung W. Choi, Shawn G. Clouthier, Rork Kuick, David E. Misek, Kenneth R. Cooke, Carrie L. Kitko, Angela Weyand, Daniel Bickley, Dawn Jones, Joel Whitfield, Pavan Reddy, John E. Levine, Samir M. Hanash, James L. M. Ferrara
Journal: Blood
Blood (2009) 113 (2): 273–278.
https://doi.org/10.1182/blood-2008-07-167098
Published: 2009
Includes: Supplemental data
Journal Articles

Elafin Is a Biomarker of Graft Versus Host Disease of the Skin

Sophie Paczesny, MD, PhD., John E. Levine, MD, Jason Hogan, PhD., Jeffrey Crawford, Thomas Braun, PhD, Hong Wang, PhD., Vitor Faca, PhD, Qing Zhang, Sharon Pitteri, PHD, Alice Chin, Sung Choi, MD, Carrie Kitko, MD, Oleg I. Krijanovski, PhD, MD, Pavan Reddy, MD, Shin Mineishi, MD, Joel Whitfield, Dawn Jones, RN, Samir Hanash, MD, PhD, James L.M. Ferrara, MD
Journal: Blood
Blood (2008) 112 (11): 716.
https://doi.org/10.1182/blood.V112.11.716.716
Published: 2008
Journal Articles

Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML.

Shin Mineishi, MD, John Magenau, MD, Attaphol Pawarode, MD, Timothy Buck, Dawn Jones, RN, Koji Kato, MD, David Frame, Pharm.D, Lisa Kujawski, MD, Harry Paul Erba, MD, PhD, Yasser Khaled, MD, Edward M. Peres, MD, Oleg I. Krijanovski, PhD, MD, Pavan Reddy, MD, Carrie Kitko, MD, Sung Choi, MD, Gregory A. Yanik, MD, Thomas Braun, PhD, James L.M. Ferrara, MD, John E. Levine, MD
Journal: Blood
Blood (2008) 112 (11): 2150.
https://doi.org/10.1182/blood.V112.11.2150.2150
Published: 2008
Journal Articles

The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Gregory A. Yanik, Vincent T. Ho, John E. Levine, Eric S. White, Thomas Braun, Joseph H. Antin, Joel Whitfield, Joseph Custer, Dawn Jones, James L. M. Ferrara, Kenneth R. Cooke
Journal: Blood
Blood (2008) 112 (8): 3073–3081.
https://doi.org/10.1182/blood-2008-03-143412
Published: 2008
Journal Articles

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

Brief Report
Sung W. Choi, Carrie L. Kitko, Thomas Braun, Sophie Paczesny, Gregory Yanik, Shin Mineishi, Oleg Krijanovski, Dawn Jones, Joel Whitfield, Kenneth Cooke, Raymond J. Hutchinson, James L. M. Ferrara, John E. Levine
Journal: Blood
Blood (2008) 112 (4): 1539–1542.
https://doi.org/10.1182/blood-2008-02-138867
Published: 2008
Journal Articles

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

John E. Levine, Sophie Paczesny, Shin Mineishi, Thomas Braun, Sung W. Choi, Raymond J. Hutchinson, Dawn Jones, Yasser Khaled, Carrie L. Kitko, Daniel Bickley, Oleg Krijanovski, Pavan Reddy, Gregory Yanik, James L. M. Ferrara
Journal: Blood
Blood (2008) 111 (4): 2470–2475.
https://doi.org/10.1182/blood-2007-09-112987
Published: 2008
Includes: Supplemental data
Journal Articles

Etanercept Plus Methylprednisolone as Initial Therapy for Acute GVHD.

John E. Levine, MD, MS, Sophie Paczesny, MD, Shin Mineishi, MD, Thomas Braun, PhD, Sung W. Choi, MD, Raymond J. Hutchinson, MD, MS, Dawn Jones, RN, Yasser Khaled, MD, Carrie Kitko, MD, Oleg Krijanovski, MD, Pavan Reddy, MD, Gregory Yanik, MD, James L.M. Ferrara, MD
Journal: Blood
Blood (2007) 110 (11): 39.
https://doi.org/10.1182/blood.V110.11.39.39
Published: 2007
Journal Articles

A Four Protein Plasma Fingerprint of Acute Graft Versus Host Disease (GVHD) Predicts Long Term Survival.

Sophie Paczesny, MD, Sung Choi, MD, Thomas Braun, PhD, Carrie Kitko, MD, Krijanovski Oleg, MD, Shawn G. Clouthier, Angela Weyand, Dan Bickley, Dawn Jones, RN, Joel Whitfield, John E. Levine, MD, James L. Ferrara, MD
Journal: Blood
Blood (2007) 110 (11): 38.
https://doi.org/10.1182/blood.V110.11.38.38
Published: 2007
Journal Articles

Changes in TNFR1 Levels in the First Week Post-Myeloablative HSCT Correlate with Severity and Incidence of GVHD and 1y TRM.

John E. Levine, MD, MS, Carrie Kitko, MD, Gregory Yanik, MD, Thomas Braun, PhD, Sophie Paczesny, MD, Shin Mineishi, MD, Oleg Krijanovski, MD, Dawn Jones, RN, Kenneth R. Cooke, MD, Joel Whitfield, Raymond J. Hutchinson, MD, MS, James L.M. Ferrara, MD
Journal: Blood
Blood (2006) 108 (11): 37.
https://doi.org/10.1182/blood.V108.11.37.37
Published: 2006